AbbVie Inc. (NYSE:ABBV) is a top non-tech stock to buy, with a $70 million expansion project underway in Massachusetts. The biopharmaceutical company focuses on immunology treatments and is set to grow with new facilities and product lines.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing